Pancreatic Adenocarcinoma
284 clinical trials · Condition
◉ Watch Pancreatic Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma (NCT07573215) | Revolution Medicines, Inc. | |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute |
Track Pancreatic Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.